Dishman Carbogen Amcis Limited (DCAL.NS) NSE
197.06
-2.04(-1.02%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
197.06
-2.04(-1.02%)
Currency In INR
Sector
Healthcare
Industry
Biotechnology
Employees
1132
First IPO Date
April 22, 2004
| Name | Title | Pay | Year Born |
| Himani S. Dhotre | Chief Executive Officer of Projects & Operations | 0 | N/A |
| Deohooti Janmejay Vyas | Whole Time Director | 12M | 1951 |
| Alan Fischer | Chief Technology Officer of CARBOGEN AMCIS | 0 | N/A |
| Martin Schneider | Chief Quality & Compliance Officer of CARBOGEN AMCIS | 0 | 1959 |
| Lucie Framinet | Marketing Manager | 0 | N/A |
| Arpit Janmejay Vyas | Global MD & Director | 0 | 1986 |
| Dharmesh Desai | GM of Secretarial & Legal | 0 | N/A |
| Harshil R. Dalal | Global Chief Financial Officer | 0 | N/A |
| Paolo Armanino | Chief Operating Officer of Indian Operations | 0 | N/A |
| Shrima Gaurangbhai Dave | Compliance Officer & Company Secretary | 0 | N/A |
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.